Literature DB >> 1137727

Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

H Minatoya, B A Spilker.   

Abstract

1. Tachyphylaxis to heart rate and bronchodilator effects of (plus or minus)-isoprenaline was studied in anaesthetized open-chest dogs by 5 procedures. 2. Heart rate responses to a series of intravenous injections of isoprenaline were essentially unchanged before and after a 15 min infusion of isoprenaline (at 3 doses). 3. Heart rate and bronchodilator responses in the same animal to an intravenous injection of isoprenaline were not significantly different before and after a 30 min infusion of isoprenaline (at 2 doses). 4. Heart rate responses were relatively constant to an isoprenaline injection given every 30 min during a 4 h infusion of isoprenaline (at 3 doses), but the magnitude of the response was smallest for the largest infusion dose (highest background heart rate) and greatest for the smallest infusion dose (lowest background heart rate). 5. Heart rate and bronchodilator responses in the same animal to isoprenaline were relatively constant during a 5 h infusion of isoprenaline (at 2 doses). 6. Bronchodilator responses to intratracheally administered isoprenaline aerosol were essentially unchanged during a 4-5 h period using various doses and procedures. 7. Tachyphylaxis to the heart rate of bronchodilator effects of isoprenaline was not observed. The present data give no support to the hypothesis that tachyphylaxis to isoprenaline aerosols is an important mechanism in asthma mortality.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137727      PMCID: PMC1666415          DOI: 10.1111/j.1476-5381.1975.tb07368.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  A COMPARISON OF THE EFFECTS OF ISOPROTERENOL IN THE NORMAL AND ASTHMATIC SUBJECT. A PRELIMINARY REPORT.

Authors:  D U COOKSON; C E REED
Journal:  Am Rev Respir Dis       Date:  1963-11

2.  Effect of aerosol isoprenaline on blood-gas tensions in severe bronchial asthma.

Authors:  K N Palmer; M L Diament
Journal:  Lancet       Date:  1967-12-09       Impact factor: 79.321

3.  Comparative study of duration of action and cardiovascular effects of bronchodilator aerosols.

Authors:  B J Freedman; G B Hill
Journal:  Thorax       Date:  1971-01       Impact factor: 9.139

4.  A comparison of the cardiorespiratory effects of salbutamol and isoproterenol-phenylephrine aerosols in asthma.

Authors:  W D Riding; S S Chatterjee; A Bernstein; P Dinda
Journal:  Am Rev Respir Dis       Date:  1971-11

5.  Mutal suppression of cardiovascular effects of some beta-adrenoreceptor agonists in the cat.

Authors:  J M Atkinson; M J Rand
Journal:  J Pharm Pharmacol       Date:  1968-12       Impact factor: 3.765

6.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

7.  Asthma mortality and pressurised aerosols.

Authors:  H Herxheimer
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

8.  Letter: Increase in asthma mortality.

Authors:  B Spilker
Journal:  Br Med J       Date:  1973-10-20

9.  Bronchodilator effects of sympathomimetic amines given singly and in combination.

Authors:  L Q Pun; M W McCulloch; M J Rand
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

10.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more
  2 in total

1.  Proceedings: Alterations to vasodilator effects of isoprenaline in the dog following intra-arterial infusions with isoprenaline, salbutamol and orciprenaline.

Authors:  P S Collier; R G Shanks
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

2.  Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigs.

Authors:  A A Anderson; G M Lees
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.